BR112012003560A8 - bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica - Google Patents

bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica

Info

Publication number
BR112012003560A8
BR112012003560A8 BR112012003560A BR112012003560A BR112012003560A8 BR 112012003560 A8 BR112012003560 A8 BR 112012003560A8 BR 112012003560 A BR112012003560 A BR 112012003560A BR 112012003560 A BR112012003560 A BR 112012003560A BR 112012003560 A8 BR112012003560 A8 BR 112012003560A8
Authority
BR
Brazil
Prior art keywords
alcoholic beverage
producing
pharmaceutical composition
compositions
alcoholic
Prior art date
Application number
BR112012003560A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112012003560A2 (pt
Inventor
Czarnik Anthony
McKinney Jeffrey
Original Assignee
Protia Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protia Llc filed Critical Protia Llc
Publication of BR112012003560A2 publication Critical patent/BR112012003560A2/pt
Publication of BR112012003560A8 publication Critical patent/BR112012003560A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12CBEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C12/00Processes specially adapted for making special kinds of beer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • C12G3/04Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/05Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
BR112012003560A 2009-08-21 2010-08-20 bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica BR112012003560A8 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US27487509P 2009-08-21 2009-08-21
US61/274,875 2009-08-21
US28086009P 2009-11-09 2009-11-09
US61/280,860 2009-11-09
US28352409P 2009-12-04 2009-12-04
US61/283,524 2009-12-04
US12/777,238 2010-05-10
US12/777,238 US8658236B2 (en) 2009-08-21 2010-05-10 Alcoholic compositions having a lowered risk of acetaldehydemia
PCT/US2010/046211 WO2011022682A1 (en) 2009-08-21 2010-08-20 Alcoholic compositions having a lowered risk of acetaldehydemia

Publications (2)

Publication Number Publication Date
BR112012003560A2 BR112012003560A2 (pt) 2020-10-27
BR112012003560A8 true BR112012003560A8 (pt) 2020-12-01

Family

ID=43605849

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012003560A BR112012003560A8 (pt) 2009-08-21 2010-08-20 bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica

Country Status (32)

Country Link
US (6) US8658236B2 (https=)
EP (1) EP2467465B1 (https=)
JP (1) JP5862965B2 (https=)
KR (1) KR101462740B1 (https=)
CN (2) CN103300449B (https=)
AP (1) AP3676A (https=)
AU (1) AU2010284051B2 (https=)
BR (1) BR112012003560A8 (https=)
CA (1) CA2771166C (https=)
CL (1) CL2012000448A1 (https=)
CO (1) CO6511227A2 (https=)
CY (1) CY1119041T1 (https=)
DK (1) DK2467465T3 (https=)
EA (1) EA023867B1 (https=)
ES (1) ES2635730T3 (https=)
GE (1) GEP20146057B (https=)
HR (1) HRP20171225T1 (https=)
HU (1) HUE036124T2 (https=)
IL (1) IL218201A (https=)
LT (1) LT2467465T (https=)
ME (1) ME02866B (https=)
MX (1) MX2012002089A (https=)
MY (1) MY156177A (https=)
NZ (1) NZ598452A (https=)
PL (1) PL2467465T3 (https=)
PT (1) PT2467465T (https=)
RS (1) RS56120B1 (https=)
SG (1) SG178521A1 (https=)
SI (1) SI2467465T1 (https=)
SM (1) SMT201700397T1 (https=)
WO (1) WO2011022682A1 (https=)
ZA (1) ZA201202075B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3135656T3 (pl) 2011-06-20 2019-07-31 H. Lundbeck A/S Deuterowane 1-piperazyno-3-fenyloindany do leczenia schizofrenii
US20140083057A1 (en) 2012-04-05 2014-03-27 Anheuser-Busch, Llc Methods of transporting decarbonated beer base liquid
CN104684555A (zh) 2012-09-18 2015-06-03 奥斯拜客斯制药有限公司 囊泡单胺转运体2的氘化苯并喹啉抑制剂的制剂药代动力学
US9713330B1 (en) 2013-03-15 2017-07-25 Deuteria Agrochemicals, Llc Deuterium-enriched aldehydes
CN105101792A (zh) 2013-03-15 2015-11-25 杜特里亚农用化学品有限责任公司 氘富集醛类
CA2961608C (en) * 2014-09-16 2023-02-07 Robert Brocia Energy drinks and other nutritional aids derived from agave-based spirits
CN107406370A (zh) * 2014-12-09 2017-11-28 以西结·戈兰 酒精饮料替代品
HRP20221106T1 (hr) 2015-03-06 2022-11-25 Auspex Pharmaceuticals, Inc. Postupci liječenja abnormalnih nevoljnih poremećaja pokreta
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US10289381B2 (en) * 2015-12-07 2019-05-14 Motorola Mobility Llc Methods and systems for controlling an electronic device in response to detected social cues
CA3059761A1 (en) 2017-04-27 2018-11-01 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from d2
JP7064507B2 (ja) 2017-04-27 2022-05-10 デューテリア ビバレッジズ、エルエルシー D2oからの重水素化エタノールの調製方法
CN109330632B (zh) * 2018-11-09 2023-09-29 上海导向医疗系统有限公司 活检旋切装置
EP3891134A1 (en) 2018-12-03 2021-10-13 H. Lundbeck A/S Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine
JP7519655B2 (ja) * 2019-02-26 2024-07-22 つばめBhb株式会社 成形焼結体および成形焼結体の製造方法
US10582716B1 (en) 2019-06-14 2020-03-10 Lennham Pharmaceuticals, Inc. Deuterated caffeine and uses thereof
MX2022005127A (es) 2019-10-29 2022-08-04 Tmrw Life Sciences Inc Aparato para facilitar la transferencia de especimenes biologicos almacenados en condiciones criogenicas.
US11817187B2 (en) 2020-05-18 2023-11-14 TMRW Life Sciences, Inc. Handling and tracking of biological specimens for cryogenic storage
USD963194S1 (en) 2020-12-09 2022-09-06 TMRW Life Sciences, Inc. Cryogenic vial carrier
EP4259333B1 (en) 2020-12-10 2026-03-04 TMRW Life Sciences, Inc. Specimen holder with wireless transponder
EP4252009B1 (en) 2021-01-13 2025-03-05 TMRW Life Sciences, Inc. System to pick and/or place specimen containers
US12194046B2 (en) 2021-03-09 2025-01-14 Lennham Pharmaceuticals, Inc. D9-caffeine compositions and uses thereof
US12527318B2 (en) 2021-10-08 2026-01-20 TMRW Life Sciences, Inc. Systems, apparatus and methods to pick and/or place specimen containers

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5156408A (en) * 1974-11-08 1976-05-18 Piasu Chem Co Karubonsanno jusuisokaesuteruno seizohoho
DE3413085A1 (de) 1984-04-06 1985-10-24 Henkell & Co, 6200 Wiesbaden Verfahren zum herabsetzen des alkoholgehalts alkoholhaltiger getraenke, insbesondere wein und schaumwein
US4612196A (en) 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
US5223269A (en) 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
JPH05156408A (ja) * 1991-11-29 1993-06-22 Nippon Steel Corp 溶接性に優れた高強度マルテンサイトステンレス鋼とその製造方法
DE4343838C2 (de) 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
CN1143308A (zh) * 1994-01-06 1997-02-19 Hyd探索发展有限公司 预防疾病发生的食品及其制备方法
WO1995018545A1 (en) * 1994-01-06 1995-07-13 Hyd Kutató-Fejlesztó Ktf. Food products for preventing development of diseases and process for preparing same
CN1087725C (zh) 1994-03-25 2002-07-17 同位素技术有限公司 用氘代方法增强药物效果
GB2293100A (en) 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide
KR100387229B1 (ko) 1995-11-01 2003-08-21 삼성전자주식회사 영상부호화장치
US6376531B1 (en) 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
DE10361313B4 (de) 2003-12-19 2008-04-10 Südzucker AG Mannheim/Ochsenfurt Alkoholarme Biere oder bierähnliche Erfrischungsgetränke mit Palatinose
DE602005027492D1 (de) * 2005-02-08 2011-05-26 Sergey Pavlovich Soloviev Mit 1h2160 angereichertes alkoholisches getränk
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+,k+-atp酶氘代抑制剂
US7713773B2 (en) * 2005-11-02 2010-05-11 Solopower, Inc. Contact layers for thin film solar cells employing group IBIIIAVIA compound absorbers
US20080301122A1 (en) * 2007-05-31 2008-12-04 Amadeus S.A.S. Searching techniques
US20090046823A1 (en) * 2007-08-14 2009-02-19 Texas Instruments Incorporated Neutron generating device

Also Published As

Publication number Publication date
US20160137959A1 (en) 2016-05-19
MY156177A (en) 2016-01-15
EA023867B1 (ru) 2016-07-29
SG178521A1 (en) 2012-04-27
CA2771166C (en) 2015-02-24
US11298317B2 (en) 2022-04-12
MX2012002089A (es) 2012-07-03
HRP20171225T1 (hr) 2017-10-20
AP3676A (en) 2016-04-16
IL218201A (en) 2015-09-24
PL2467465T3 (pl) 2017-11-30
EA201290097A1 (ru) 2012-08-30
CL2012000448A1 (es) 2012-08-31
US9044423B2 (en) 2015-06-02
US20150011651A1 (en) 2015-01-08
EP2467465A1 (en) 2012-06-27
CN103300449B (zh) 2015-05-06
KR20120053510A (ko) 2012-05-25
HK1171245A1 (en) 2013-03-22
US20190062680A1 (en) 2019-02-28
ES2635730T3 (es) 2017-10-04
EP2467465B1 (en) 2017-06-07
GEP20146057B (en) 2014-03-10
WO2011022682A1 (en) 2011-02-24
SI2467465T1 (sl) 2017-09-29
CO6511227A2 (es) 2012-08-31
KR101462740B1 (ko) 2014-11-17
CA2771166A1 (en) 2011-02-24
CN102471742A (zh) 2012-05-23
US10731116B2 (en) 2020-08-04
CN103300449A (zh) 2013-09-18
LT2467465T (lt) 2017-11-27
CY1119041T1 (el) 2018-01-10
RS56120B1 (sr) 2017-10-31
PT2467465T (pt) 2017-09-11
US20210038511A1 (en) 2021-02-11
US9732311B2 (en) 2017-08-15
NZ598452A (en) 2012-12-21
US8658236B2 (en) 2014-02-25
US20180030394A1 (en) 2018-02-01
CN102471742B (zh) 2013-05-29
HUE036124T2 (hu) 2018-06-28
JP2013502227A (ja) 2013-01-24
EP2467465A4 (en) 2013-09-25
JP5862965B2 (ja) 2016-02-16
IL218201A0 (en) 2012-04-30
DK2467465T3 (en) 2017-09-11
AU2010284051B2 (en) 2014-12-04
ZA201202075B (en) 2013-08-28
BR112012003560A2 (pt) 2020-10-27
AU2010284051A1 (en) 2012-03-08
US20110046236A1 (en) 2011-02-24
US10047330B2 (en) 2018-08-14
AP2012006133A0 (en) 2012-02-29
SMT201700397T1 (it) 2017-09-07
ME02866B (me) 2018-04-20

Similar Documents

Publication Publication Date Title
BR112012003560A8 (pt) bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica
MX338712B (es) Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma.
BR112013000537A2 (pt) composição aquosa contendo bromexina
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
ECSP11011048A (es) Inhibidores de cinasa akt y p70 s6
BR112012011328A2 (pt) inibidores de akt
EA201791850A1 (ru) Борсодержащие малые молекулы
BR112012022513A2 (pt) derivados de piperidin-4-il azetidina como inibidores de jak1
BR112012006692A2 (pt) composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
MX338535B (es) Inhibidores de ibat para el tratamiento de enfermeades hepaticas.
CR11623A (es) Compuestos
MY166653A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
EA201071167A1 (ru) Стабилизированные олеосомные композиции и способы их получения
BR112013025777A2 (pt) imidazopiridazinas como inibidores da quinase akt
BRPI0815474A8 (pt) Método para produzir um alimento ou bebida à base de malte apropriado para consumo por um indivíduo com doença celíaca
BR112014009376A2 (pt) composições
ECSP12011959A (es) SALES DE 4-[2-[[5-METIL-1-(2-NAFTALENIL)-1H-PIRAZOL-3-il]OXI]ETIL]MORFOLINA
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
BR112014002823A2 (pt) processo para a medição de uma quantidade de enzimas digestivas liberadas de uma composição em um meio de dissolução e processo para a medição da quantidade de enzimas digestivas liberadas de uma composição sólida em meio de dissolução por espectroscopia de fluorescência combinado com um teste de gastrorresistência
MX2010009147A (es) Derivados de pirrolidinilo y usos de los mismos.
CL2010001566A1 (es) Compuesto derivado de piperidinilo, modulador de la actividad de los receptores de la quimiocina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, alergicas, autoinmune.
BR112013000840A2 (pt) método para aumentar o efeito de forma ativada potencializada de anticorpo para molécula endógena biológica, composição farmacêutica e uso de combinação de molécula biológica endógena com forma ativada potencializada de anticorpo para a sintase no endotelial.
BR112014032254A2 (pt) processo para a preparação de uma composição, aparelho, e, uso de um aparelho
BRPI0814808B8 (pt) processo para preparação de óleo ou manteiga de sapucainha e uso de óleo ou manteiga de sapucainha

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25B Requested transfer of rights rejected

Owner name: DEUTERIA BEVERAGES, LLC. (US)

Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870180058830 DE 06/07/2018, EM VIRTUDE DO PEDIDO JA ESTAR EM NOME DO INTERESSADO.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: PROTIA LLC (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.2 NA RPI NO 2601 DE 10/11/2020 POR TER SIDO INDEVIDA.

B25A Requested transfer of rights approved

Owner name: DEUTERIA BEVERAGES, LLC. (US)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]